Hoth Therapeutics (NASDAQ:HOTH) changed 4.00% to recent value of $3.12. The stock transacted 65850 shares during most recent day however it has an average volume of 216.51K shares. It spotted trading -65.60% off 52-week high price. On the other end, the stock has been noted 20.23% away from the low price over the last 52-weeks.
On April 17, 2020, Hoth Therapeutics (NASDAQ:HOTH) a biopharmaceutical company, announced the addition of two independent members, Mr. Graig Springer and Mr. Wayne Linsley, to its Board of Directors. The Company also released the resignation of current board member, Mr. Anthony Hayes.
Management is pleased to announce the addition of two experienced and successful leaders to our Board, said Mr. Robb Knie, Chief Executive Officer of Hoth Therapeutics. I am confident that their experience in business management, financial reporting and capital markets will serve us well as we continue our growth and development. We look forward to leveraging their insights and experience.
Mr. Knie continued, Anthony Hayes has been a trusted colleague and advisor for many years. On behalf of my fellow directors, the company’s management team, and shareholders, I’d like to thank him for the significant contributions he made during his service on Hoth’s Board, we wish him the best in his future endeavors.
Its earnings per share (EPS) expected to touch remained -69.50% for this year.
The company has 11.76M of outstanding shares and 5.14M shares were floated in the market. According to the most recent quarter its current ratio was 6 that represents company’s ability to meet its current financial obligations. The price moved ahead of 1.71% from the mean of 20 days, -17.40% from mean of 50 days SMA and performed -32.72% from mean of 200 days price. Company’s performance for the week was -0.32%, 11.43% for month and YTD performance remained -49.60%.